Safety and comfort are vital to help infants with their earliest steps in life. Intersurgical offer a range of patient interfaces specifically designed to provide non-invasive respiratory support for the smallest and most sensitive patients.

The Intersurgical portfolio includes solutions for Nasal High Flow (NHF), Continuous Positive Airway Pressure (CPAP) and Non-invasive Ventilation (NIV) therapies, for a range of patient sizes, from the smallest neonates to pre-adolescents.

Related Pages

nFlow™ infant nasal CPAP breathing systems

infant-patient-interfaces-nflow-infant-nasal-cpap-450x250

nFlow™ system offers a complete care solution for infant CPAP with established gas flip technology, providing a low work of breathing option as an alternative to ventilator CPAP. We offer a choice of two nFlow™ styles: the traditional eyelet bonnet system and our new CosyFit™ system design. The CosyFit™ bonnet makes attaching the generator simple and precise and helps create a secure yet gentle fit for even the most sensitive patients. Patient interfaces and bonnets are supplied separately to avoid waste, and the size guide helps choosing the correct option for your patient.

View the product range and supporting material

MiniMe®2 paediatric nasal NIV mask

infant-patient-interfaces-minime-2-450x250

MiniMe®2 is a single-patient use paediatric nasal NIV mask for use in the hospital or homecare environment, with service life of six months. MiniMe®2 is available in four sizes, both with vented and non-vented options for CPAP and bilevel therapy. Designed for children ages 2-12, the MiniMe®2 mask features AIRgel® with Advanced Cushion Technology™ and mouldable shell, providing your smallest patients the ultimate fit and maximum comfort.

View the product range and supporting material

MiniMe®2 and AIRºgel® are registered trademarks of Sleepnet Corporation. Touchless Spacebar and Advanced Cushion Technology are trademarks of Sleepnet Corporation.

For further information about our Infant Patient Interfaces range please contact us.

 

Make an enquiry

Back to the top